Section Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar University
Verified email at QU.edu.qa
Cited by
Cited by
Pre-fusion structure of a human coronavirus spike protein
RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ...
Nature 531 (7592), 118-121, 2016
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ...
Nature 499 (7456), 102-106, 2013
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ...
Nature medicine 21 (9), 1065-1070, 2015
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants
LJ Abu-Raddad, H Chemaitelly, AA Butt
New England Journal of Medicine, 2021
Evaluation of candidate vaccine approaches for MERS-CoV
L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ...
Nature communications 6 (1), 1-11, 2015
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2
N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ...
Viruses 12 (6), 582, 2020
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ...
Science translational medicine 7 (309), 309ra162-309ra162, 2015
Structural and genetic basis for development of broadly neutralizing influenza antibodies
D Lingwood, PM McTamney, HM Yassine, JRR Whittle, X Guo, ...
Nature 489 (7417), 566-570, 2012
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses
MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ...
Cell 166 (3), 609-623, 2016
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
JE Ledgerwood, CJ Wei, Z Hu, IJ Gordon, ME Enama, CS Hendel, ...
The Lancet infectious diseases 11 (12), 916-924, 2011
Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages
JRR Whittle, AK Wheatley, L Wu, D Lingwood, M Kanekiyo, SS Ma, ...
Journal of virology 88 (8), 4047-4057, 2014
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
Viruses 11 (8), 762, 2019
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Clinical Infectious Diseases, 2020
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 385 (24), e83, 2021
Isolation, molecular characterization and antimicrobial resistance patterns of Salmonella and Escherichia coli isolates from meat-based fast food in Lebanon
S Harakeh, H Yassine, M Gharios, E Barbour, S Hajjar, M El-Fadel, ...
Science of the Total Environment 341 (1-3), 33-44, 2005
Viral-induced enhanced disease illness
MK Smatti, AA Al Thani, HM Yassine
Frontiers in microbiology 9, 2991, 2018
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ...
Nature immunology 20 (3), 362-372, 2019
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ...
Nature medicine 27 (9), 1614-1621, 2021
Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses
HM Yassine, MQ Al-Natour, CW Lee, YM Saif
Virology journal 4 (1), 1-9, 2007
H5N1 vaccine–elicited memory B cells are genetically constrained by the IGHV locus in the recognition of a neutralizing epitope in the hemagglutinin stem
AK Wheatley, JRR Whittle, D Lingwood, M Kanekiyo, HM Yassine, SS Ma, ...
The Journal of Immunology 195 (2), 602-610, 2015
The system can't perform the operation now. Try again later.
Articles 1–20